Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
Comparing Consumer Staples ETFs: IYK, KXI, and RSPS for Defensive Positioning

Comparing Consumer Staples ETFs: IYK, KXI, and RSPS for Defensive Positioning

Key Takeaways

  • All three funds target consumer staples, but their construction differs fundamentally: IYK is a U.S.-focused, market-cap-weighted fund; KXI is a global, market-cap-weighted fund; and RSPS is a U.S. equal-weighted fund.
  • Expense ratios are clustered tightly between 0.38% and 0.40%, meaning cost is not the decisive factor in this comparison.
  • Diversification depth diverges sharply: KXI holds roughly 100+ global names, IYK about 55 U.S. names, and RSPS about 36 equal-weighted U.S. names.
  • Concentration risk is highest in IYK, which carries a heavy tilt toward tobacco and mega-cap staples, while RSPS minimizes single-name risk through equal weighting.
  • Tickeron AI Verdict: KXI — favored for its broadest global diversification, balanced sector exposure, and more resilient risk-adjusted positioning.

Setting the Stage for Consumer Staples ETFs

Consumer staples ETFs remain a key part of defensive portfolio construction, giving exposure to companies that provide essential goods like food, beverages, and household products. Comparing IYK, KXI, and RSPS makes sense now because these funds cover the same sector yet follow three different strategies. IYK focuses on the U.S. staples market with a concentrated, cap-weighted approach; KXI extends that reach worldwide; and RSPS avoids mega-caps through equal weighting. Understanding these differences helps when assessing sector exposure and relative positioning.

IYK: U.S.-Focused Staples Exposure

IYK tracks the Russell 1000 Consumer Staples 22.5/45 Capped Index, a benchmark of U.S. staples equities with limits on single-stock weights. The fund is passively managed and market-cap-weighted, with about 55 holdings. Top positions include PG at roughly 13%, KO near 12%, PM around 11%, plus PEP, CVS, and MO. Sector allocation leans heavily toward consumer defensive at about 85%, with an 11% healthcare component. The expense ratio stands at 0.38%, and the low beta highlights its defensive profile. I also checked the holdings breakdown using Tickeron’s AI Screener to confirm the concentration levels.

KXI: Broadening Horizons Globally

KXI follows the S&P Global 1200 Consumer Staples Sector Capped Index, offering market-cap-weighted access to staples companies around the world. The portfolio includes more than 100 holdings across about 20 countries. Leading names feature WMT at approximately 8%, COST near 7%, along with PG, KO, PM, PEP, and international names such as Nestlé, Unilever, and British American Tobacco. U.S. exposure accounts for around 60%, with additional weight in the United Kingdom, Japan, Switzerland, and France. The expense ratio is 0.39%, and the global scope helps spread single-country and currency risks.

RSPS: Equal Weighting for Balance

RSPS tracks the S&P 500 Equal Weight Consumer Staples Index, assigning roughly equal weight to each of its approximately 36 U.S. staples holdings. This quarterly-rebalanced structure prevents any single company from driving results. Top positions sit near 3% each and include DLTR, TGT, HRL, KMB, DG, GIS, KDP, and MNST. The portfolio is almost entirely consumer defensive at about 97%. Its expense ratio is 0.40%, the highest of the three, while assets under management remain the smallest.

Navigating the Staples Sector Today

The consumer staples sector continues to serve as a defensive anchor amid ongoing inflation, uneven spending, and changing promotional patterns. Rising input costs and price sensitivity have weighed on volume growth for packaged foods and beverages, while GLP-1 weight-loss treatments raise longer-term questions about demand. A strong U.S. dollar affects multinational earnings, impacting KXI’s international holdings more than the domestic-focused IYK and RSPS. Heavy tobacco exposure in both IYK and KXI also brings regulatory and volume risks.

Performance Insights and Positioning

Recent performance among the three funds has shown modest divergence tied to their structures. IYK’s concentrated mega-cap and tobacco tilt has captured strength in large defensive names but also heightens single-stock risks. KXI’s global footprint has delivered smoother returns with added currency variability. RSPS’s equal-weight method has trailed over longer periods as smaller staples names lagged mega-caps, yet it reduces the chance of one holding dominating losses. On a risk-adjusted basis, KXI’s breadth has supported steadier positioning.

Integrating Tickeron’s AI Screener

In my research process, I often rely on Tickeron’s AI Screener to compare ETFs across technical patterns, fundamentals, and performance metrics. This helps surface structural differences quickly and supports more informed decisions when evaluating funds like these three staples options. It has become a regular part of how I refine sector comparisons without replacing deeper analysis.

AI-Driven Verdict on These ETFs

Based on structural strength, diversification depth, cost efficiency, and risk-adjusted positioning, the analysis points to KXI as the favored choice. Its portfolio of more than 100 holdings across developed international markets delivers the broadest diversification, lowering single-name and single-country risks while keeping a comparable expense ratio. Although IYK has a slightly lower fee and RSPS reduces single-stock dominance, KXI’s geographic reach and balanced footprint support more stable momentum. This view reflects structural characteristics rather than a specific recommendation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IYK, KXI, RSPS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IYK's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.

Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Philip Morris International (NYSE:PM), PepsiCo (NASDAQ:PEP), Altria Group (NYSE:MO), McKesson Corp (NYSE:MCK), CVS HEALTH Corp (NYSE:CVS), Mondelez International (NASDAQ:MDLZ), Colgate-Palmolive Company (NYSE:CL), Kroger Co (The) (NYSE:KR).

Industry description

The investment seeks to track the investment results of the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index composed of U.S. equities in the consumer staples sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index, The underlying index measures the performance of the consumer staples sector of the U.S. equity market. It is non-diversified.

Market Cap

The average market capitalization across the iShares U.S. Consumer Staples ETF (IYK) ETF is 49.78B. The market cap for tickers in the group ranges from 3.09B to 411.62B. KO holds the highest valuation in this group at 411.62B. The lowest valued company is FRPT at 3.09B.

High and low price notable news

The average weekly price growth across all stocks in the iShares U.S. Consumer Staples ETF (IYK) ETF was -3%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 8%. TSN experienced the highest price growth at 11%, while USD experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the iShares U.S. Consumer Staples ETF (IYK) ETF was 18%. For the same stocks of the ETF, the average monthly volume growth was 72% and the average quarterly volume growth was 77%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 49
Price Growth Rating: 46
SMR Rating: 58
Profit Risk Rating: 72
Seasonality Score: 13 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.